| Nr. | Numele studiului | Status | Locatia/Locatiile studiului |
| 1 | A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (CheckMate 9DX) | In curs de recrutare | Local Institution, Brasov, Romania, 500091, Contact: Site 0060 Local Institution, Bucharest, Romania, 022328, Contact: Site 0078 Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0232 Local Institution, Constanta, Romania, 900591, Contact: Site 0242 Local Institution, Craiova, Romania, 200347, Contact: Site 0074 S.C. Oncocenter Oncologie Clinica S.R.L., Timisoara, Romania, 300166, Contact: Roxana-Ioana Scheusan, Site 0070 +40745146020 |
| 2 | Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib (CELESTIAL) | Activ, inca nu se recruteaza | Cluj-Napoca, Cluj, Romania, 400015Brasov, Romania, 500019 |
| 3 | A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma (CheckMate 9DW) | In curs de recrutare | Local Institution, Craiova, Dolj, Romania, 200347, Contact: Site 0103 Local Institution, Bucharest, Romania, 22328, Contact: Site 0164 Local Institution, Cluj Napoca, Romania, 400015, Contact: Site 0165 Local Institution, Craiova, Romania, 200385, Contact: Site 0208 Local Institution, Timisoara, Romania, 300166, Contact: Site 0163 |
| 4 | Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) | Activ, inca nu se recruteaza | Spitalul Pelican Impex SRL- Sectia Oncologie Medicala, Bihor, RomaniaInstitutul Clinic Fundeni – Sectia Oncologie Medicala, Bucuresti, RomaniaClinica Bendis – Oncologie Medicala, Cluj, RomaniaCentrul de Oncologie ONCOLAB, Dolj, RomaniaInstitutul Regional de Oncologie Iasi – Sectia Oncologie Medicala, Iaşi, RomaniaSC DACMED SRL – Oncologie, Prahova, RomaniaSpitalului Clinic Judetean de Urgenta – Sectia Oncologie Medicala, Sibiu, RomaniaSpitalul Judetean de Urgenta „Sf. Ioan Cel Nou” – sectia Oncologie Medicala, Suceava, Romania |
| 5 | Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy (COSMIC-312) | In curs de recrutare | Exelixis Clinical Site #204 Active, not recruiting Cluj-Napoca, Cluj, Romania, 400015 Exelixis Clinical Site #211 Active, not recruiting Cluj-Napoca, Cluj, Romania, 400015 Exelixis Clinical Site #202 Active, not recruiting Cluj-Napoca, Cluj, Romania, 400641 Exelixis Clinical Site #206 Active, not recruiting Bucuresti, Romania, 022328 Exelixis Clinical Site #209 Active, not recruiting Iaşi, Romania, 700483 |
| 6 | Contrast Enhanced Ultrasound Guidance Biopsy for the Diagnosis of Liver Tumors (ConCLUDe) | In curs de recrutare | Regional Institute of Gastroenterology and Hepatology „Octavian Fodor” Recruiting Cluj-Napoca, Please Enter The State Or Province, Romania, 400126 Contact: Tudor Mocan +40 799 861946 Mocan.Tudor@umfcluj.ro Contact: Ioana Rusu ioana.russu@yahoo.com |
(Visited 55 times, 1 visits today)